EGF and neoplasm: The tumor and normal tissue uptake of bispecific [64Cu]Cu-NOTA-trastuzumab Fab-PEG24-EGF or monospecific [64Cu]Cu-NOTA-trastuzumab Fab or [64Cu]Cu-NOTA-EGF were determined at 48 h p.i. in mice with MDA-MB-468 tumors or tumors formed by inoculating a mixture of MDA-MB-468 cells (70%) and SK-OV-3 cells (30%).